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Background: Increased prenatal testosterone exposure has been hypothesized as a mechanism underlying autism
spectrum disorders (ASD). However, no studies have prospectively measured prenatal testosterone exposure and
ASD. The current study sought to determine whether testosterone concentrations in umbilical cord blood are
associated with a clinical diagnosis of ASD in a small number of children and with autistic-like traits in the general
population.
Methods: Umbilical cord blood was collected from 707 children. Samples were analyzed for total (TT) and
bioavailable (BioT) testosterone concentrations. Parent report indicated that five individuals had a clinical diagnosis
of ASD. Those participants without a diagnosis were approached in early adulthood to complete the
Autism-Spectrum Quotient (AQ), a self-report measure of autistic-like traits, with 184 males (M = 20.10 years;
SD= 0.65 years) and 190 females (M = 19.92 years; SD=0.68 years) providing data.
Results: The BioT and TT concentrations of the five children diagnosed with ASD were within one
standard-deviation of the sex-specific means. Spearman’s rank-order coefficients revealed no significant correlations
between TT levels and scores on any AQ scale among males (rho range: -.01 to .06) or females (rho value range: -.07
to .01). There was also no significant association between BioT or TT concentrations and AQ scores among males
(rho value range: -.07 to .08) or females (rho value range: -.06 to .12). Males were more likely than females to have ‘high’
scores (upper decile) on the AQ scale relating pattern and detail processing. However, the likelihood of a high score on
this scale was unrelated to BioT and TT concentrations in both males and females.
Conclusions: These findings indicate that testosterone concentrations from umbilical cord blood are unrelated to
autistic-like traits in the general population. However, the findings do not exclude an association between testosterone
exposure in early intrauterine life and ASD.
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Autism Spectrum Disorder (ASD) is the collective term
for neurodevelopmental conditions characterized by
impairments in social interaction and communication,
and a restricted range of activities and interests [1].
While the biological pathways contributing to ASD* Correspondence: awhitehouse@ichr.uwa.edu.au
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distribution, and reproduction in any mediumremain unclear, current consensus is for a multifactorial
etiology, incorporating a constellation of genetic risk
variants, perhaps interacting with environmental factors
[2]. Males are between two and four times more likely to
receive a diagnosis of ASD than females [3-5], and it has
been suggested that this sex bias may provide clues as to
the biological mechanisms subserving the condition
[6,7]. Testosterone, the most biologically significant an-
drogen, is a small lipophilic molecule that is able to pass
the blood–brain barrier and cell membranes, and bind
with androgen receptors found in the cytoplasm of cells.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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metabolite, dihydrotestosterone) molecules are bound,
this structure is able to enter the nucleus, where it binds
to DNA and affects transcription. The developing male
fetus has considerably higher circulating testosterone
levels compared to the female fetus [8], and animal studies
have confirmed that prenatal testosterone exposure
impacts upon fetal neurodevelopment both within and
between sexes [9].
For many years, the primary way to investigate pre-
natal hormone exposure in humans was through an
examination of ‘proxy measures’ of exposure, such as
human finger-length patterns. Testosterone is thought
to stimulate prenatal growth of the fourth finger while
estrogen promotes growth of the second finger [10]. On
average, males have a longer fourth digit relative to their
second digit, while women have comparable second and
fourth digit lengths [11]; a sex-difference that has been
observed as early as the first trimester [12,13]. A lower
2D:4D ratio (indicating exposure to greater levels of tes-
tosterone) has been found among children with ASD
and their relatives [14,15]. Further indirect evidence
linking prenatal testosterone exposure and the ASD
phenotype has emerged from studies of patient popula-
tions with excessive androgen exposure, such as females
with Congenital Adrenal Hyperplasia (CAH). Most cases
of CAH result from a genetic deficiency in the enzyme
21-hydroxylase, leading to an overproduction of adrenal
androgens, such that female fetuses with CAH have pre-
natal androgen levels elevated to within or above the
typical male range. Knickmeyer and colleagues [16]
reported that females with CAH may have increased
levels of autistic-like traits compared to non-affected sib-
lings, particularly with regard to social difficulties and
restricted interests, while another small study found an
elevated rate of testosterone-related disorders among
females with a clinical diagnosis of ASD, such as Poly-
cystic Ovarian Syndrome and hirsutism [17]. Delayed
menarche has also been linked with the ASD pheno-
type [18,19], although the association between prenatal
testosterone exposure and age of menarche is incon-
sistent [20].
More direct evidence linking prenatal testosterone and
the ASD phenotype has emerged from an ongoing longi-
tudinal study of typically developing children for whom
amniotic fluid was collected during the second prenatal
trimester. Testosterone levels within the amniotic fluid
samples were found to predict reduced eye contact at 12
months of age [21] and the quality of social relationships
and level of restricted interests at age 4 and 8 years [22],
as well as scores on a range of questionnaires measuring
autistic-like behaviors, including the Quantitate CHeck-
list for Autism in Toddlers at age 18 to 24 months [23],
and the Child Autism Spectrum Test and Autism-Spectrum Quotient- Child Version [24] between 6 and
10 years of age. Further analysis of the Autism-Spectrum
Quotient-Child Version revealed amniotic fluid testos-
terone concentrations were positively associated with
scores on all four subscales (Mind reading, Attention to
detail, Social skills and Imagination). However, studies of
this cohort have also limited their investigation to total
testosterone levels only. Most circulating testosterone is
bound to steroid hormone binding globulin (SHBG) and
a smaller fraction to albumin. It is the 1% to 2% free
fraction that is biologically active [25]. Measurements of
total testosterone (TT), particularly during pregnancy
when SHBG and albumin are increased, may not reflect
free testosterone levels. Furthermore, studies measuring
testosterone in amniotic fluid samples are limited by a
certain sample demographic. Amniocentesis is per-
formed only in high-risk pregnancies, most commonly
for increased risk of fetal karyotypic abnormalities. Par-
ticipant samples are not representative of the broader
population of pregnant women, which may confound
any study of prenatal testosterone exposure.
Umbilical cord blood presents another opportunity for
estimating the prenatal hormone environment. Samples
of cord blood can be obtained at delivery in both low
and high risk pregnancies, and therefore randomly
selected participant samples are more likely to be repre-
sentative of the general population. A number of studies
have reported higher testosterone levels in cord blood
samples from male versus female fetuses [26,27], and
thus these samples are thought to reflect fetal circulation
during late gestation. A limitation of this approach is
that testosterone levels in cord blood may not reflect
concentrations during the earlier stages of pregnancy.
Gestational weeks 8 to 24 have traditionally been
regarded as a ‘sensitive period’ for the maximal effects
of sex steroids on neurodevelopment [9]. While second
trimester amniotic fluid samples are able to measure
this critical window, umbilical cord samples are not.
However, there is increasing recognition that there may
be multiple sensitive periods, and animal studies have
found that different neural regions may be affected by
hormones at different times throughout prenatal devel-
opment [28]. Investigations of the Western Australian
Pregnancy Cohort (Raine) Study have provided evi-
dence that umbilical cord blood can provide important
data on testosterone and its effect on postnatal develop-
ment, finding a 2.5-fold increase in the rate of language
delay among males with high levels of cord-blood tes-
tosterone [29].
Here, we report a follow-up of the Raine cohort, repre-
senting the first investigation of the prospective relation-
ship between umbilical cord testosterone concentrations
and autistic characteristics. Cord blood was available for
a small number of individuals with a clinical diagnosis of
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in early adulthood on the remainder of the available co-
hort. The measure of autistic-like traits was treated as a
continuous variable, but was also dichotomized at the
threshold of the upper decile, in order to determine
whether perinatal testosterone levels were associated
with high levels of autistic-like traits in particular. We
hypothesized that increased concentrations of testoste-
rone from cord blood would be associated with
increased ASD-like traits in the whole sample, and
that those individuals with a clinical diagnosis of ASD




The Raine Study is a longitudinal investigation of
women between 16 and 20 weeks pregnancy from the
public antenatal clinic at King Edward Memorial Hos-
pital or surrounding private clinics, between May 1989
and November 1991. Approximately 100 unselected
antenatal patients per month were enrolled during this
period, with a final sample of 2,900 women. The inclu-
sion criteria were a gestational age between 16 and 20
weeks, English language skills sufficient to understand
the study demands, an expectation to deliver at King
Edward Memorial Hospital, and an intention to remain
in Western Australia to enable future follow-up of their
child [30]. By the end of the recruitment period, 2,868
live births (96%) were available for follow-up. Partici-
pant recruitment and all follow-ups of the study families
were approved by the Human Ethics Committee at Kind
Edward Memorial Hospital and/or Princess Margaret
Hospital for Children in Perth. Informed consent was
obtained from all mothers and offspring who partici-
pated in this study.
Testosterone analysis
Mixed arterial and venous umbilical cord blood was
obtained at the birth of 861 singleton deliveries (selected
randomly). Blood samples were immediately centrifuged,
plasma isolated and then stored at −80°C without thawing.
Detailed sequence analysis of DNA obtained from ten
maternal-child pairs confirmed that the cord blood
samples were not contaminated by maternal blood. In
January 2010, these serum samples were thawed and
analyzed for androgen content. TT was measured by li-
quid chromatography-tandem mass spectrometry (LC-
MS/MS) after solvent extraction as described in detail
by Keelan et al. [27]. The limit of quantitation was 0.025
ng/ml (0.08 nmol/L). Inter-batch variation was low at
6% to 11% (n = 24); recovery from cord serum was 93%
to 98%. SHBG was measured by ELISA using a commer-
cial kit (IBL International, Hamburg, Germany) accordingto the manufacturer’s instructions. All samples were mea-
sured in duplicate by a single operator using assay kits
from the same batch. The inter-assay imprecision was
<4.5% (n = 25). Intra-assay variation was 5.2% (n = 861).
Samples with an initial replicate coefficient of variation
(CV) of >10% were reanalyzed. BioT (nmol/L), represent-
ing the fraction of total testosterone either free (unseques-
tered by SHBG) or bound to serum albumin, was
calculated using the formula: BioT = [free testosterone] +
[albumin-bound testosterone] (19). Free testosterone was
calculated using the empirical method and formula
described by Sartorius et al. [31]. Albumin levels were
adjusted using published reference values to take into ac-
count the decrease in serum albumin concentrations with
gestational age [32]. For the current study, TT and BioT
were the predictor variables of interest.ASD diagnosis
At the 5-, 8-, 10-, 14- and 17-year follow-ups of the
Raine cohort, parents were asked whether their child
had ever received a diagnosis of ASD by a health profes-
sional. Diagnosis of these conditions in Western Australia
mandates consensus by a team comprising a pediatrician,
psychologist and speech-language pathologist under Diag-
nostic and Statistical Manual of Mental Disorders, 4th
Edition (DSM-IV), guidelines [1].Autism-spectrum quotient (AQ)
At age 19 to 20 years, the cohort was invited to
complete the Autism Spectrum Quotient (AQ). Adults
with a known diagnosis of any intellectual disability or
ASD were not asked to complete the AQ due to ethical
concerns. The AQ is a self-report questionnaire that
provides a quantitative measure of autistic-like traits in
the general population [33]. Individuals are provided
with 50 statements and asked to indicate on a four-point
scale how well that statement applies to them (strongly
agree, agree, disagree, strongly disagree). Items were
scored according to the original procedure as well as an
alternative method. The original procedure outlined in
Baron-Cohen et al., allocates a score of 1 to a response
indicating an autistic-like trait (strongly agree/agree or
strongly disagree/disagree) and 0 to a response non indi-
cative of an autistic-like trait. The statements are divided
into five subscales - Social Skills, Communication, At-
tention Switching, Attention to Detail, Imagination – of
10 items each. Items within each subscale are then
summed to provide a quantitative measure of that par-
ticular autistic-like trait, with higher scores denoting
increased symptomatology. A Total AQ is calculated by
tallying the scores from the five subscales. The Total AQ
is known to have good test-retest reliability (r = 0.7), and
validation studies have found that scores in the general
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[33,34].
The AQ was also scored according to an alternative
procedure. Factor analyses of the AQ in several coun-
tries have consistently identified three clear factors, re-
lating to Social Ability, Attention to Detail/Patterns, and
Communication/Mind Reading. There is minimal differ-
ence between the items pertaining to these subscales
and those reported in other factor analyses. In the
current study, we divided items into the subscales identi-
fied in a study of Western Australian adults [35], who
were highly similar to the sample under investigation
here: Social Skills, Details/Patterns and Communication/
Mindreading. The items were scored on a scale ranging
from 1 to 4, based on previous research that this scoring
method retains more information about responses than
the dichotomous scoring first proposed for this instru-
ment [35-37]. For the current data set, internal reliability
for the scales ranged from moderate (Communication/
Mind-reading: α = .63) to good (Details/Patterns: α = .78)
and excellent (Social Skills: α = .85).
Sample characteristics
A range of variables was investigated to determine
whether the individuals with both cord blood testosterone
and AQ data were representative of the broader cohort
with BioT data. These included sociodemographic factors
recorded at 18 weeks’ pregnancy (maternal age at concep-
tion, maternal education, family income); antenatal
variables recorded at 34 weeks’ pregnancy (maternal
smoking and alcohol consumption during pregnancy);
and obstetric variables recorded at birth (gestational
age, offspring gender, parity, Apgar scores five minutes
after birth). A further variable, proportion of optimal
birthweight, provided a measure of appropriateness of
fetal growth. This variable is calculated as a ratio of the
observed birth dimension to the optimal birth dimen-
sion for that individual neonate [38].
Statistical analysis
Previous studies have identified sex-specific effects of
perinatal testosterone exposure [29], and therefore all
analyses were conducted separately for males and
females. The first analysis examined concentrations of
umbilical cord TT and BioT levels among the children
with a parent-reported diagnosis of ASD. Raw scores
were also converted to sex-specific Z-scores to enable a
comparison of individual data points with the distribu-
tion of the broader sample.
The analyses then turned to the analysis of individuals
with both testosterone and AQ data. For these data, we
sought first to determine whether these participants
were representative of the broader Raine Study cohort.
TT/BioT concentrations and AQ scores were theninvestigated as both continuous and categorical data.
AQ data were analyzed in accordance with the original
scoring procedure [33], as well as the alternative scoring
procedure outlined in the Methods [35]. With regards to
the continuous variables, independent-samples t-tests
examined whether there were sex differences in AQ
scores. Given evidence that males score higher than
females on the AQ and its subscales, one-tailed tests
were conducted [33,37]. Our hypothesis is that early tes-
tosterone exposure is one potential reason for between
sex-differences in autistic-like characteristics. As such,
only those AQ scales in which there was a significant
sex-difference in scores were examined further. For
these scales, we conducted correlations between BioT
and TT concentrations from umbilical cord blood and
AQ scores. Any significant correlation was then followed
up using hierarchical multivariate linear regression.
Covariates that showed a correlation with the outcome
variable (score on relevant AQ scale) at the level of
P <.2 were included in the first block using the enter
method, while concentrations of the predictor variable
(TT or BioT) were added in the second block. For all
analyses, an alpha level of 0.05 was adopted to indicate
statistical significance.
We then investigated the data when expressed
categorically to determine whether early testosterone ex-
posure was associated with high scores on the AQ and
its subscales. ‘High’ scores were defined as scores in the
upper decile of a particular scale (to the nearest whole
number). Chi-square analyses examined whether there
were sex differences in the proportion of males and
females with high scores on AQ each scale (both original
and alternative scoring). Again, only those scales in
which there was a significant sex-difference were exam-
ined further. For these scales, chi-square analyses were
conducted separately for each sex between sex-specific
quartiles of testosterone concentrations and high scores
on the particular AQ scale. Any significant difference on
any scale was followed up with multivariate logistic re-
gression, following the same three-step procedure out-
lined for the multivariate linear regression. The alpha
level for all analyses was P <.05.
Results
Clinical ASD
Among the 861 children with available BioT data, 707
(82.1%) provided diagnostic data at any of the 5-, 8-, 10-,
14- or 17-year follow-ups. Parent report indicated that 5
of the 707 (0.71%) children had received a clinical diag-
nosis of ASD. One male and one female had been diag-
nosed with Autistic Disorder, and three males had been
diagnosed with Asperger’s Disorder. TT (BioT) concen-
trations for males with ASD ranged from 0.25 to 0.70
nM/L (0.079 to 0.22 nM/L), which compared to a mean
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and a standard deviation of 0.36 nM/L (0.11 nM/L). The
cord blood TT (BioT) concentration for the female with
Autistic Disorder was 0.17 nM/L (0.05 nM/L), which
was less than the mean of the broader female sample of
0.30 nM/L (0.09 nM/L) and standard deviation of 0.19
nM/L (0.07 nM/L). Table 1 presents sex-specific Z-scores
for the TT and BioT concentrations of the individuals with
ASD. All Z-scores were between −1 and 1, indicating that
BioT concentrations were within one standard deviation
of the sex-specific means.
Autistic-like traits
Among the 707 individuals who had provided some
postnatal diagnostic data, 184 of 365 (50.4%) males and
190 of 342 (55.6%) females also completed the AQ. Al-
though there was a statistically significant sex-difference
in age at the time of AQ completion, t(372) = 2.73,
P = .01, the absolute difference between males (M =
20.10 years; SD = 0.65 years) and females (M = 19.92
years; SD = 0.68 years) was small (Cohen’s d = 0.27).
Table 2 presents the sociodemographic characteristics of
these participants in comparison to the remainder of
individuals with BioT data available. Chi-square analyses
revealed that participants who did not complete the AQ
had mothers who were younger, less educated, more
likely to smoke cigarettes and have a family income
below the poverty line ($AUD24,000) at the time of
pregnancy. However, there was no difference between
individuals who did and did not complete the AQ in
gestational age at birth, proportion of optimal birth-
weight, and parity or Apgar scores five minutes after
birth. Furthermore, there was no significant difference in
BioT levels between those who did and did not contribute
AQ data for both males, t(340) = 0.67, P = .51, and
females, t(362) = 1.40, P = .16. Therefore, while the
current sample was representative of the broader Raine
cohort in terms of obstetric factors, they were exposed to
a more socially advantageous environment.
Continuous data
Table 3 presents descriptive statistics for predictor (TT
and BioT) and outcome (AQ scores) variables for malesTable 1 Testosterone concentrations from umbilical cord bloo
Bioavailable testosterone
Sex Raw value (nM/L) Sex-spe
Autism 1 Male .35 −
Autism 2 Female .17 −
Asperger 1 Male .70
Asperger 2 Male .25 −
Asperger 3 Male .35 −
ASD, autism spectrum disorder.and females. Independent-samples t-tests confirmed that
males had significantly greater levels of TT and BioT
compared to females (P <.01). Analyses of the original
AQ scales revealed only one significant sex difference,
which was for the Imagination subscale, where males
had significantly higher scores than females (P = .01).
Analyses of the alternative AQ scales found that males
scored higher than females on the Total AQ (P = .02), as
well as the Social Skills (P = .04) and the Details/Pat-
terns subscales (P <.01). There were no statistically sig-
nificant differences between the scores of males and
females on the Total, Social Skills, Communication, At-
tention Switching and Attention to Detail scales scored
according to the original procedure, and no difference
on the Communication/Mindreading scale scored
according to the alternative procedure.
Testosterone concentrations were positively skewed
(skewness statistic greater than 1 for BioT and TT for
both males and females), and, therefore, Spearman’s
rank-order correlations were conducted (Table 4). There
were no significant correlations between predictor and
outcome variables at the level of P <.05 for either sex.
Spearman’s rho ranged from -.07 to .08 for males, and
-.06 to .12 for females. Figures 1a and 1b present the
raw data between BioT concentrations and the Total AQ
score (alternative scoring) for males and females, re-
spectively. Given the small effects observed and the lack
of statistical significance, multivariate linear regression
analyses were not conducted.
Categorical data
High score thresholds (upper decile) for the various AQ
scales are shown in Additional file 1. Chi-square analyses
revealed a sex difference in the proportion of individuals
with high scores on one AQ scale only (Table 5). Males
(13%) were significantly more likely than females (5.3%)
to have a high score on the Details and Patterns subscale
(alternative scoring), Χ2 = 6.85, df = 1, P <.01. No other
sex differences were observed.
Quartile markers for BioT concentrations among
males were <0.083 nM/L (n = 46), 0.084 to 0.112 nM/L
(n = 46), 0.113 to 0.162 nM/L (n = 46), and >0.162 nM/
L (n = 46) for Quartiles 1 to 4, respectively. For females,d of the individuals with ASD
Total testosterone






Table 2 Characteristics of participants with testosterone data, who did or did not complete the Autism-Spectrum
Quotient (AQ)
Completed AQ (n = 374) Did not complete AQ (n = 332)
Categorical variables N n (%) N n (%) P value
Maternal age at birth 366 320 <.01
<20 19 (5.2) 32 (10.0)
20-24 65 (17.8) 73 (22.8)
25-29 91 (24.9) 107 (33.4)
30-34 120 (32.8) 76 (23.8)
35+ 71 (19.4) 32 (10.0)
Maternal education at pregnancy 366 320 .01
Completed secondary school 156 (42.6) 104 (32.5)
Did not complete secondary school 210 (57.4) 216 (67.5)
Family income below poverty line 364 318 <.01
Yes 115 (31.6) 149 (46.9)
No 249 (68.4) 169 (53.1)
Maternal smoking in pregnancy 366 320 .01
None 293 (80.1) 223 (69.7)
1 to 10 cigarettes daily 42 (11.5) 56 (17.5)
11+ cigarettes daily 31 (8.5) 41 (12.8)
Maternal alcohol intake during pregnancy 366 320 .01
None 199 (54.4) 212 (66.3)
Once a week or less 143 (39.1) 88 (27.5)
Several times a week or more 24 (6.6) 20 (6.3)
Gestational age 366 320 .36
< 32 weeks 3 (0.8) 7 (2.2)
32 to 37 weeks 64 (17.5) 48 (15.0)
38 to 40 weeks 231 (63.1) 210 (65.6)
> 40 weeks 68 (18.6) 55 (17.2)
Proportion of optimal birthweight 372 332 .41
<90 117 (31.5) 96 (28.9)
90 to 110 208 (55.9) 183 (55.1)
>110 47 (12.6) 53 (16.0)
Sex 374 332 .14
Male 190 (50.8) 181 (54.5)
Female 184 (49.2) 151 (45.5)
Apgar scores 366 319 .94
Generally normal 353 (96.4) 308 (96.6)
Fairly low 13 (3.6) 11 (3.4)
Critically Low 0 (0) 0 (0)
Parity 374 332 .51
1 167 (44.7) 159 (47.9)
2 121 (32.4) 95 (28.6)
>2 86 (23.0) 78 (23.5)
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Table 3 Mean (SD) of testosterone and Autism-Spectrum Quotient (AQ) scores
Males (N = 184) M (SD) Females (N = 190) M(SD) P value Cohen’s d
Total testosterone (nM/L) 0.49 (0.26) 0.27 (0.15) <.01 1.03
Bioavailable testosterone 0.13 (0.06) 0.08 (0.04) <.01 0.98
AQ original scoring
Total 15.10 (4.78) 14.70 (5.31) .23 0.08
Social Skills 1.51 (1.67) 1.68 (1.76) .18 0.09
Communication 2.03 (1.57) 1.98 (1.68) .39 0.03
Attention Switching 3.83 (1.90) 3.78 (1.98) .32 0.03
Attention to Detail 5.34 (2.10) 5.24 (1.99) .37 0.05
Imagination 2.39 (1.57) 2.03 (1.48) .01 0.24
AQ alternative scoring
Total 104.46 (12.23) 102.11 (10.53) .02 0.19
Social Skills 24.66 (5.58) 23.64 (5.85) .04 0.18
Details/Patterns 20.16 (4.63) 18.74 (4.35) <.01 0.32
Communication/Mindreading 15.01 (2.88) 15.42 (3.50) .22 0.12
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L (n = 48), 0.069 to 0.098 nM/L (n = 48) and >0.99 nM/
L (n = 47) for Quartiles 1 to 4, respectively. Given the
very high correlations between TT and BioT levels, quar-
tiles for TT were not analyzed. Chi-square analyses
(Table 6) found that the proportion of high scores on
the Details and Patterns subscale of the AQ (alternative
scoring) did not significantly vary as a function of BioT
quartiles in males, Χ2 = 1.15, df = 3, P <.77, and females,
Χ2 = 6.07, df = 3, P = .11. The null results meant that no
logistical regression analyses were conducted.
Sample attrition
Sample attrition was biased towards variables indexing
lower socioeconomic strata. As a final set of post-hoc
analyses, we examined whether Total AQ scores (ori-
ginal scoring procedure) in the current sample varied
according to these factors. Independent-samples t-tests
found that Total AQ scores were significantly higher for
those adults whose mother was living below the poverty
line during pregnancy (below poverty line: M = 15.82,
SD = 5.09; above poverty line: M = 14.45, SD = 5.08;
P = .02), and whose mother had not completed secondaryTable 4 Spearman’s correlations (P value) between testostero
Quotient (AQ)a
1 2
1. Total testosterone 1 .94 (<.01)
2. Bioavailable testosterone .91 (<.01) 1
3. Original: Imagination .09 (.23) .12 (.11)
4. Alternative: Total AQ -.03 (.68) .01 (.85)
5. Alternative: Social Skills -.06 (.45) .01 (.95)
6. Alternative: Details/Patterns -.05 (.49) -.01 (.87)
aMale correlations (n = 184) are above the diagonal, and female correlations (n = 1school at the time of pregnancy (not completed secondary
school: M = 15.53, SD = 4.73; completed secondary school:
M = 14.25 , SD = 5.35; P = .01). However, analysis of
variance (ANOVA) found that AQ scores in the current
sample did not differ as a function of maternal age at con-
ception, F(4, 361) = 0.50, P = .76, and maternal smoking
during pregnancy, F(2, 363) = 1.11, P = .33.Discussion
Exposure to increased levels of prenatal testosterone has
received increasing attention as a possible biological
mechanism contributing to ASD. However, ASD is first
recognized through behavioral symptoms during early
childhood, and, therefore, data on the prenatal hormone
environment are rare. This is the first report of the rela-
tionship between testosterone concentrations in umbili-
cal cord blood and the ASD phenotype. Five children in
the current sample had received a clinician-based diagno-
sis of ASD. Four of the five cases had TT and BioT levels
lower than the sex-specific BioT means of the broader co-
hort, and all cases were within one standard deviation of
these means. A measure of autistic-like traits, the AQ, wasne concentrations and scores on the Autism-Spectrum
3 4 5 6
-.04 (.60) .01 (.89) .05 (.47) .06 (.40)
-.07 (.35) .02 (.80) .07 (.36) .06 (.46)
1 .42 (< .01) .14 (.06) .02 (.82)
.40 (<.01) 1 .67 (<.01) .37 (<.01)
.19 (.01) .70 (<.01) 1 .05 (.47)
.03 (.68) .48 (<.01) .20 (.01) 1
90) are below the diagonal.
Figure 1 Scatterplots (and fit lines) showing the associations between bioavailable testosterone from umbilical cord blood (BioT) and
total AQ scores in early adulthood in males (Figure 1a) and females (Figure 1b).
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ASD. Males scored higher than females on the three
scales, but none of these were significantly correlated
with early testosterone measurements (in males or
females). Males were more likely than females to have
‘high’ scores on the Details and Patterns subscale of the
AQ (but no other subscale). However, again, this scalewas found to be unrelated to early testosterone concen-
trations. While the small number of individuals with a
clinical diagnosis of ASD evokes caution in the inter-
pretation of these data, we suggest that the current
findings indicate that testosterone concentrations mea-
sured at the time of birth are not associated with
autistic-like traits in the general population.
Table 5 Number (%) of participants with ‘high’ scores on Autism-Spectrum Quotient (AQ) scores
Males (N = 184) n (%) Females (N = 190) n (%) P value Cramér’s Phi
AQ original scoring
Total 20 (10.9) 22 (11.6) .83 0.01
Social Skills 8 (4.3) 15 (7.9) .15 0.07
Communication 17 (9.2) 16 (8.4) .78 0.08
Attention Switching 13 (3.1) 14 (7.4) .91 0.01
Attention to Detail 34 (18.5) 27 (14.2) .26 0.06
Imagination 16 (8.7) 10 (5.3) .19 0.07
AQ alternative scoring
Total 24 (13.0) 18 (9.5) .27 0.06
Social Skills 18 (9.8) 17 (8.9) .78 0.01
Details/Patterns 24 (13.0) 10 (5.3) <.01 0.14
Communication/Mindreading 17 (9.2) 16 (8.4) .78 0.08
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vided the most direct evidence linking prenatal testoster-
one exposure and ASD, reporting associations between
testosterone levels in amniotic fluid and a range of
autistic-like traits during early [21-23] and middle [24]
childhood. Amniotic fluid samples from the Cambridge
cohort were collected via amniocentesis during the second
trimester of pregnancy (18 to 20 weeks gestation). One
possible explanation for the null findings observed in the
current study relates to the timing of testosterone expos-
ure. Hormone concentrations are known to fluctuate
throughout pregnancy [39], with considerable variability
between measurements taken in the second and third tri-
mesters [40]. In the current study, DNA sequencing con-
firmed that the cord blood samples were free from
maternal blood contamination, and the higher concentra-
tions of BioT in male compared to female offspring sug-
gest that these samples reflect fetal circulation during late
gestation. The lack of association between cord blood
concentrations of BioT and autistic-like traits suggests
that either prenatal testosterone does not influence these
behaviors, or that any effects are at an earlier gestation.
It is also possible that the effects of prenatal testosterone
exposure are determined not only by individual differ-
ences in concentration, but also by individual differences
in biological sensitivity to testosterone. The neuroactive
effects of testosterone occur either through the activation
of the X chromosome linked androgen receptor AR gene,
located at Xq11-12, or after aromatization to estradiol,Table 6 The number (%) of participants with high scores on t
testosterone concentrations
Bioavailable testosterone concentrations
Quartile 1 (lowest) Quartile 2 Quartile
Males 6 (13.0) 5 (10.9) 5 (10.9)
Females 2 (4.3) 0 (4.2) 2 (4.2)through the estrogen receptor [41]. The cysteine, adenine,
guanine (CAG) repeat sequence within exon 1 of the an-
drogen receptor gene, is of particular interest because it is
highly polymorphic. This CAG repeat codes for a polyglu-
tamine tract of variable length in the N-terminal domain
of the protein, and the number of repeats is inversely
related to the transcriptional activity of androgen target
genes [42,43]. It remains possible that testosterone levels
during late gestation are associated with the ASD pheno-
type, but these effects are modified by individual genotype.
However, it is important to note that studies of testos-
terone concentrations in both amniotic fluid [21-24]
and cord-blood [29] have reported associations with
postnatal behavior when naïve to individual genotype.
We suggest that future studies in this area may benefit
from an understanding of the genetic as well as endo-
crine background of an individual.
A further explanation for the null findings relates to
the pattern of AQ scores observed in the current sam-
ple. The primary hypothesis of the current study – that
perinatal testosterone concentrations are associated with
autistic-like traits - was formulated based on widely
observed sex-differences in ASD [6]. However, for the
majority of AQ scales scored according to the original
procedure [33], there were no differences in scores be-
tween males and females. This finding contrasts with
studies from the Cambridge Fetal Testosterone Project,
which have observed sex-differences in scores on other
measures of autistic-like traits, including the Quantitatehe Details and Patterns scale according to bioavailable
3 Quartile 4 (highest) P value Cramér’s Phi
8 (17.4) .77 .08
5 (10.6) .11 .15
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month-old toddlers [23], and the Child Autism Spectrum
Test and Autism-Spectrum Quotient-Child Version [24]
among children between 6 and 10 years of age. It is pos-
sible that sample attrition may have contributed to the
lack of sex differences in AQ scores, given that AQ
scores were typically higher for socially disadvantaged
participants, and that these individuals were less likely
to take part in the current study. Importantly, however,
sex differences were observed when an alternative scoring
procedure of the AQ was applied [35], and these scales
showed no association with early testosterone exposure
in either sex.
Strengths of the current study include the relatively
large sample size, the prospective longitudinal design
spanning over two decades, and the highly sensitive and
selective LC-MS/MS assay used to measure testosterone
levels in umbilical cord blood. One potential concern is
that degradation may have occurred in storage or with
thawing, resulting in reduced concentrations of intact
steroids. However, we believe such concerns are un-
founded for several reasons. First, our sample set had
been continually maintained at −80°C since collection
and samples were thawed only once for aliquotting prior
to shipping for assay. Studies of steroid stability (including
testosterone) during long term storage confirm that serum
samples are able to be stored for at least four decades
at −80°C without loss or appreciable deterioration of
steroid hormones [44,45]. Second, freshly collected
cord blood samples run as quality controls (n = 5 to 6)
had values within one standard deviation of the means
of the frozen samples, adding further weight to the view
that no significant degradation had taken place; our stabili-
ty studies showed no effects of several freeze-thaw cycles.
Finally, our recovery estimates based on spiking of fresh
cord serum were 93% to 111% indicating that the assays
did not suffer from masking or interference effects.
A limitation of the study design was that the ascertain-
ment of the five ASD cases in this study was dependent
upon parent-report of a clinician-based diagnosis (by a
pediatrician, psychologist and speech pathologist)
according to DSM-IV guidelines at any of the 5-, 8-, 10-,
14- or 17-year follow-ups. While it is commonplace in
ASD research to confirm clinical diagnoses using ASD-
specific behavioral observation and/or parent interview
assessments, this was not possible within the Raine co-
hort. However, it is important to note that a previous in-
vestigation of direct observation data obtained prior to
five years of age [46], found that each ASD case in the
current study demonstrated behaviors consistent with
ASD (for example, poor eye contact, delayed language,
absence of pretend play). Moreover, the overall rate of
ASD within the current sample was 0.71%, which is
highly similar to the most recent population-basedprevalence estimates in Australia (0.625%) [47], and sug-
gests that there was no systematic bias introduced to the
study by our reliance on clinician diagnosis.
A further limitation is that sample attrition in the
current investigation, as for many longitudinal studies,
appeared to bias the loss of individuals from lower
socioeconomic strata. Post hoc analyses found that AQ
scores varied according to maternal income and educa-
tion, which raises the concern that the attrition may
have underestimated any effect of maternal umbilical
cord blood testosterone concentrations on AQ scores.
However, published studies reporting significant associa-
tions between amniotic fluid testosterone levels and post-
natal behavior [23,24], have included selected samples
(that is, high-risk pregnancies undergoing amniocentesis)
and experienced similar attrition effects. Furthermore,
computer simulations using data from the Avon Longi-
tudinal Study of Parents and Children (United King-
dom) have found that selective dropout in cohort
studies only marginally affect regression coefficients, if
participant selection occurs according to predictor
variable(s) [48]. For these reasons, we suggest that the
sample attrition in the current study had minimal, if
any, influence on the null finings observed.
Conclusions
The current study found no evidence that testosterone
concentrations from umbilical cord blood are related to
autistic-like traits in the general population. The findings
suggest that any link between prenatal testosterone con-
centration and ASD may be restricted to exposure during
the earlier stages of gestation, or due to individual differ-
ences in the biological sensitivity to testosterone.
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